The industrial biotech firm has entered into an agreement with India-based Sea6 Energy to jointly develop a process for the production of biofuels from seaweed. The research alliance will use enzymes to convert seaweed-based carbohydrates to sugar, which can then be fermented to produce ethanol for fuel, fine chemicals, proteins for food, and fertilizers for plants.

Novozymes will research, develop, and manufacture enzymes for the conversion process, while Sea6 Energy contributes its offshore seaweed cultivation technology. “Seaweed is a natural complement to our efforts to convert other types of biomass to fuel ethanol,” says Per Falholt, Executive Vice President and CSO of Novozymes. “More than half of the dry mass in seaweed is sugar, and the potential is therefore significant.”

Sea6 Energy is currently trialing its cultivation technology in partnership with a few fishing communities around the coastal areas of South India. Novozymes’ Indian arm will work closely with Sea6 Energy to develop the conversion technology.

BASF, through subsidiary BASF Biorenewable Beteiligungs GmbH & Co. KG led a $50 million financing round in the technology firm Renmatix Inc.

Renmatix has developed the patented Plantrose™ platform whereby industrial sugar can be produced from lignocellulosic biomass (wood, cane trash or straw). In the Plantrose technology, biomass is split into cellulose and sugar in supercritical water at high temperature and pressure in a two-step process.

Industrial sugars are important renewable resources for the chemical industry and can be used, for example, to produce biofuels or basic chemical products and intermediates by fermentative processes. The availability of industrial sugars in sufficient quantities and at favorable cost is therefore important for the competitiveness of the products.

In addition, the study found that four in 10 American consumers and about a third of Canadian consumers have already heard the term “biobased” to describe various products including fuels such as ethanol and biodiesel, as well as cleaning and personal care products and clothing.

“I think very clearly that they know what a green product is, but haven’t yet made the link on how we’re going to make those products green and how important biobased products are going to be,” said Tjerk de Ruiter, CEO of Genencor.

“It was very interesting to see that ethanol was at the top of the list. Now of course we were very pleased with that because ethanol is such an important product and such an important marketplace for us,” said de Ruiter. “But it also shows that the consumer really starts to buy in to the concept of the importance of home produced fuels and really the contribution that ethanol is delivering to the economy.”

Listen to my interview with Tjerk de Ruiter here: Genencor Household Sustainability Index

I asked de Ruiter how biobased enzymes, such as their product, differed from what we’ve seen in the past. “When you work with a biobased organism, you can continuously improve. If we look at the enzyme systems we have today, they are a lot more efficient allowing you to extract a lot more alcohol, or ethanol, out of the product itself, and quite often at lower temperatures and in the process reducing energy use,” said de Ruiter.

Other products consumers found to be green were detergents, cosmetics and some clothing. The survey will be used to create a baseline to determine if “biobased” products become better understood, accepted and adopted by consumers. Click here to learn more.

Click here to see photos from the 2011 BIO World Congress.

The program partners are in the process of developing a black liquor and lignin evaluation centre in Thunder Bay, Ontario. At the core is the lignin demonstration plant that ties directly into the black liquor stream of AbitibiBowater’s Thunder Bay kraft pulp mill. When fully operational, this one of its kind demonstration plant will produce up to 100 kg of lignin per day, which will be shipped to a network of R&D labs across Canada that are developing novel uses for wood products. Also located in this facility is a lignin characterization lab.

Lakehead University and its Biorefining Research Initiative will be closely linked to the ongoing research and will be training students and postdoctoral fellows at the facility.

“It is with cutting‐edge technologies and strong partnerships such as this one that FPInnovations is contributing to building the future of forestry in Canada,” said Pierre Lapointe, President and Chief Executive Officer for FPInnovations. “The strong ties to Lakehead University are key to keeping technology and knowledge in the North. This only strengthens Lakehead’s Biorefining Research Initiative and other related science programs by creating linkages with labs across Canada.”

The is a huge potential market for lignin‐based products. It can be used as a green alternative to many petroleum‐derived substances, such as fuels, resins, rubber additives, thermoplastic blends, nutra‐ and pharmaceuticals, and more.

Doug Murray, General Manager of AbitibiBowater’s Thunder Bay Operations, added, “The lignin evaluation plant provides us an opportunity to move wood‐based products beyond traditional markets. We are pleased to have this innovative lab at our mill site and look forward to continued progress. We feel very fortunate to be part of this initiative.”

View pictures from the 2011 BIO World Congress in my flickr photo album.

Succinic acid is a chemical building block used in the manufacture of polymers, resins, food and pharmaceuticals among other products. Bio-based succinic acid, a renewable and versatile chemical building block, is an alternative to petroleum-derived chemical building blocks such as adipic acid and 1.4-butanediol. DSM is able to produce the biochemical at a lower cost than the conventional fossil-fuel based chemical giving it an economic advantage in the marketplace.

Rob van Leen, Chief Innovation Officer of DSM, said, “The time is right to capitalize on the tremendous progress we have made together with Roquette in the last two years. Our proprietary yeast-based fermentation process not only allows cost effective production; it also eliminates salt waste and other by-products and thus improves the overall eco-footprint of end-products. This bio-based chemical building block is a substitute for various fossil feedstock derived monomers and proves that the bio-based economy is no longer a distant prospect.”

This announcement is the next in a series since the partnership began in 2008. In 2010 DSM and Roquette opened a demonstration plant in Lestrem (France), which has been running at full capacity. The two companies have also announced their intention to establish a joint venture, which will be carrying out business under the name Reverdia).

“We are very encouraged with the development efforts in several new applications and are receiving favorable feedback from customers who have sampled ton quantities from our demonstration plant in Lestrem. The new plant in Italy will allow customers in Europe, North America and Asia to make larger volume commitments to their customers,” added Jean-Bernard Leleu, Deputy CEO and RID Director of Roquette.

To view photos from the 2011 BIO World Congress visit my flickr photo album.

“We are thrilled to have these two industry leaders validate Verdezyne’s technology and its business strategy by taking a stake in the company,” said E. William Radany, Verdezyne’s CEO and president. “This new funding, along with the support from existing investors, will enable the company to execute on its goal of creating and deploying first-in-class engineered yeast strains that efficiently produce biobased fuels and platform chemicals.”

According to Verdezyne, they have significantly advanced its robust yeast production platform for their ethanol and adipic acid processes. The additional financing will allow the company to continue to build its yeast metabolic engineering capabilities to produce a pipeline of renewable transportation fuels and platform chemicals.

DSM VP of Biobased Chemicals and Fuels, James Lademarco, added, “Over the past year, we have been impressed with Verdezyne’s progress in its yeast platform for both fuels and biobased chemicals. We see this investment as strategic given the complementary activities to our own portfolio within Biobased Products and Services.”

You can view photos of the 2011 BIO World Congress in my flickr photo album.

Sijbesma believes that over the next 100 years, the world will be shifting away from the Fossil Age into the third Green Industrial Age, an age based on not taking from the land, from developing feed, fuel and fiber from the land in a sustainable manner.

“The so-called fossil-age will make a shift to the bio-based economy. In two or three centuries from now, people will look back on our civilization as a merely brief moment in history where we in a period of just about 250 years shifted our total economy to coal, oil and gas,” said Sijbesma during his acceptance speech. “To make the shift back to living with, and especially off, nature, we need to start this shift now. We are at a turning point towards a next green industrial revolution to secure our feed and fuel needs in the future.”

Listen to my interview with Feike Sijbesma here: The Next Green Industrial Revolution Begins with Biotech

Sijbesma believes biotechnology holds the key to our future and will provide solutions for energy and food.

“Today people are concerned about food first and then fuel and I understand that. If you use the sugar component from crops to make fuel I understand with all the starvation in the world why people are concerned,” said Sijbesma. “However, you have second generation biofuels already today where we can use the waste components or the cellulose components, which is more complicated. But we’ve shown today a breakthrough in C5 & C6 sugars where we can covert all the waste in the plant towards ethanol so second generation biofuels are a solution.”

“But I go further in the vision for the future. There are so many proteins in all kinds of side streams in crops which we are not using today. We use them for landfill and sometimes for animal feed, etc. but not for human consumption. And if we all want to eat more proteins, more meat proteins, which is not possible, then we need to find a different source of proteins,” said Sijbesma. “And I think with biotechnology, we can get those from the crops. And that means in the future, still 10 years to go, but if we develop the technology it can be food and fuel.”

Also honored today was Iowa State University (ISU) student Catherine E. Brewer who is working on her Ph.D. in chemistry. Brewer received a scholarship and one area that she is focused on is soil science. George Washington Carver, a graduate of ISU is considered one of the founding fathers of the chemurgy movement, a precursor to industrial biotechnology.

DSM also announced today that together with partner Roquette will build a new commercial scale plant in Italy to produce bio-based succinic acid sourced from local feedstocks. Also during the conference, DSM announced the result of a work with Abengoa to develop their C5/C6 advanced yeast technology for the conversion of second generation biofuels.

View pictures from the 2011 BIO World Congress in my flickr photo album.

“G2 BioChem’s technology is feedstock agnostic and optimizes next-generation ethanol yields using all available sugars,” began Barry Wortzman, President of G2 BioChem during the press conference. “Also, our process technology results in a low cost, per litre, which is essential to the viable commercialization of next generation ethanol.”

Listen to Barry Wortzman’s remarks during the press conference: Greenfield Ethanol Launches G2 BioChem

G2 BioChem’s research team has conducted thousands of trials and demonstrated success with various feedstocks including agricultural residues such as corn stover, corn cobs and bagasse as well as energy crops such as sorghum & miscanthus and woody biomass such as poplar.

“G2 BioChem’s advanced biofuels technology has the potential to fundamentally change the burgeoning renewable fuels and biochemical industries – while protecting our environment and boosting Ontario’s economy,” said Glen Murray, Minister, Ontario Research & Innovation. Ontario boosts the third largest biotech cluster in the world.

Listen to Glen Murray’s remarks during the press conference: Murray's Remarks during G2 BioChem Press Conference

The new collaboration was in part made possible from several industry partners including Novozymes. “As a collaborative partner, Novozymes’ goal is to enable and facilitate the realization of cellulosic ethanol production at commercial scale, as quickly as possible; and in our opinion, this technology is leading the way to accomplishing that objective,” said Cynthia Bryant, Global Business Development for Novozymes.

Listen to Cynthia Bryant’s remarks during the press conference: Bryant's Remarks during G2 BioChem Press Conference

Bertil Stromberg, VP, BioFuels for Andritz added, “Andritz is excited to be partnering on this initiative, and to contribute its expertise in process equipment technology for the commercial scale up of the process.”

Listen to Bertil Stromberg’s remarks during the press conference: Stromberg's Remarks during G2 BioChem Press Conference

Check back for audio from the announcement and click here to see photos from the 2011 BIO World Congress.

Erickson said that this conference is really dynamic on multiple levels. There are a series of plenary sessions as well as breakout sessions and workshops covering the gamut from advanced biofuels technology to algae and feedstock crops, as well as aviation fuels, renewable chemical platforms, and bi-based materials. Several events of special interest include the announcement of the George Washington Carver award and Greenfield Ethanol will be making an announcement about its cellulosic technology.

Listen to or download my interview with BIO’s Brent Erickson: BIO World Congress Preview

Two weeks ago, BIO released a white paper on policy and investments needed for the biotech industry. Erickson said these issues would be key during the World Congress. Government policy in the U.S. as well as Canada and globally will be entwined through many sessions. In addition, there will be a focus on the flow of venture capital and investment money into this space as Erickson said for many companies this is an important issue. He also said it is very heartening in this investment climate to see IPOs take place. The next IPO to take place is Solazyme.

I asked Erickson what companies or technologies he think will breakthrough over the next 6-18 months and he said what we’ll see are platforms breakthrough. He believes the biobutanol platform will take off as well as the succinic acid platform.

Be sure to follow conference conference right here beginning on Monday.

The money will also fund ongoing development work in the field of succinic acid. According to the company, this work includes work pertaining to the second generation organism being developed with Cargill, the technology licensed from DuPont that converts succinic acid to 1,4-butanediol (BDO), the novel purification process developed and scaled up with MATRIC, and the use of non-food feedstocks to produce biobased succinic acid.

“We were impressed by BioAmber’s management team, breadth of strategic partnerships and business model and we are very pleased to be the lead investor in this round,” said Carole Piwnica, Managing Partner of NAXOS and newly elected Vice-Chairman of BioAmber’s Board of Directors.

Jean-Francois Huc, CEO of BioAmber added, “We are proud to welcome NAXOS, which brings extensive industry experience, and Mitsui & Co., which has a global presence in biobased chemicals, and we are thankful for Sofinnova’s unwavering support. With our strong investor base and unrivaled partnerships, we are poised for rapid growth and long term market leadership.”

Dyadic Netherland’s General Manager, Dr. ir. Wim van der Wilden will guide the research with collaboration from Dr. Mark Alfenito, the President and CEO of EnGen Bio, an early stage biopharmaceutical company based in Redwood City, California. The research is anticipated to be completed in six to twelve months. All other terms of the research collaboration are confidential.

Mark Emalfarb, President and CEO of Dyadic added, “We are very pleased to have the opportunity to work with Sanofi Pasteur and EnGen Bio to further demonstrate the utility of our C1 technology for certain vaccine applications.

As a result of the report, the biofuel and biotech industries came out in support of the president’s commitment to biofuels.

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood thanked President Obama and his administration for its leadership in supporting the commercial development of biorefineries.

“Continued reliance on foreign petroleum threatens not only our economy, but also our energy and national security,” said Greenwood. “Next generation biorefineries utilizing renewable biomass to produce advanced biofuels, biobased products and renewable chemicals offer the potential to help stabilize energy prices and revitalize U.S. rural and manufacturing communities. The policies announced today by President Obama will provide important support to path-breaking biotechnology companies seeking to build commercial-scale cellulosic and advanced biorefineries.”

BIO’s Executive Vice President, Brent Erickson, added that to continue the momentum in the commercialization of biofuels, Congress and the country’s energy policy must enable federal agencies to serve as leaders in creating an open marketplace for biofuels to compete.

Also responding to the report was Brooke Coleman, the executive director of the Advanced Ethanol Council. Coleman reiterated that the biofuels industry is ready and waiting to assist the country in meeting its domestic energy needs and also called upon the administration to work with the industry to create a “responsible transition and transformation of current biofuel tax policy and investments in ethanol vehicle technology and fueling infrastructure.”

Coleman concluded, “Challenging capital markets, economic uncertainty, and uncertain federal policy have worked to slow the commercialization of promising advanced ethanol technologies. By committing to policies that accelerate the commercial production of ethanol from a wide range feedstocks, the nation can gain more control over its energy future. Ethanol production from wood wastes, grasses, municipal solid waste, and other non-traditional feedstocks will go a long way to making America truly independent of a need to import oil.”

The research was based on the bacteria Clostridium, where some of the species produce n-butanol, a drop-in fuel many companies are currently pursuing as a replacement for gas and diesel. Many researchers have genetically altered the bacteria to boost its ability to produce n-butanol while others have taken other routes such as plucking enzymes from the bacteria and inserted them into other microbes including E. coli. The results have only provided limited n-butanol production.

Chang and her colleagues emulated the same enzyme pathway into E. coli, but replaced two of the five enzymes with look-alikes from other organisms. This avoided one of the problems other researchers have had: n-butanol being converted back into its chemical precursors by the same enzymes that produce it.

The result was a new genetically altered E. coli strain that produced nearly five grams of n-buranol per liter, about the same as the native Clostridium and one-third the production of the best genetically altered Clostridium, but about 10 times better than current industrial microbe systems.

“We are in a host that is easier to work with, and we have a chance to make it even better,” Chang said. “We are reaching yields where, if we could make two to three times more, we could probably start to think about designing an industrial process around it. We were excited to break through the multi-gram barrier, which was challenging.”

According to an article from UC Berkeley, Chang is optimistic that by improving enzyme activity at a few other bottlenecks in the n-butanol synthesis pathway, in addition to optimizing the host microbe for production of n-butanol, she can boost production two to three times, enough to justify considering scaling up to an industrial process.

Corn farmers play a major role in helping America produce domestic, renewable fuels such as ethanol and I also spent last Saturday with more than 900 Iowa corn farmers, many who are growing corn for ethanol. The Iowa Corn Growers Association (ICGA) sponsored the game on Saturday as part of their mission to educate consumers about the role Iowa corn farmers play in producing their food and fuel.

ICGA CEO Craig Floss said that during the game, they were able to tell the story of how ethanol fits into the picture and what that means for Iowa corn farmers.

“There is no other liquid form of petroleum product like ethanol that can actually replace foreign produced oil. And the bulk of our oil comes from countries that have governments that are not like ours,” said Floss. He continued that everyone was touched by the event and has a connection to the event and we need to find a way to send less money to those countries. That is why we like corn farmers, explained Floss. They’re good for our economy and good for our security.

Floss concluded that corn farmers will continue to exceed global needs of corn and said that we haven’t even started to unlock the genetic code of what corn can do.

You can see pictures from game day in the Iowa Corn Fed Game Day photo album.

You can listen to my interview with Craig Floss here. Iowa Corn Farmers Will Reach New Heights

Officials at SG Biofuels have announced that they and Life Technologies Corporation have completed sequencing the Jatropha curcas genome to 100x coverage, using the SOLiD™ 4.0 System by Life Technologies:

The sequence significantly accelerates the identification of key traits for the oilseed-producing crop and advances its development as a high yielding, low-cost source for next generation biofuel.

Working in strategic alliance with Life Technologies, SG Biofuels will use the sequence to generate a high quality Jatropha reference genome. The genome will be compared to sequences generated from SG Biofuels’ germplasm library of more than 6,000 unique Jatropha genotypes – the largest and most diverse collection of Jatropha germplasm in the world – to identify molecular markers and trait genes to accelerate development of elite cultivars with vastly superior yields and profitability. This work will also advance the introduction of transgenic plants with further improved traits.

“The value of a Jatropha reference genome is enhanced significantly by having a diverse collection of plant material for comparison,” said Kirk Haney, President and Chief Executive Officer of SG Biofuels. “The sequence adds a powerful new tool to our development platform, allowing us to rapidly unlock the true potential of Jatropha as the most profitable and sustainable biofuel feedstock.”

“Working with SG Biofuels to sequence the Jatropha genome is an important part of our broader synthetic biology strategy to provide technologies for the development of next generation renewable energy,” said Wendy Jozsi, Director of Synthetic Biology at Life Technologies. “There is significant opportunity to use advanced molecular techniques in the optimization of plant-based biofuels, especially Jatropha, for increased yields and a faster development cycle, ultimately leading to new sources of energy.”

The non-edible jatropha is native to Central America and grown on marginal lands, providing a fuel source that does not compete with the food supply or the land to grow that food supply.

The lawsuit was originally filed in October of 2007 and asserted class action claims against its Asian subsidiaries based on allegations of misstatements and omissions by Dyadic and certain of its current and former officers and directors arising out of alleged improprieties. The company created a cash reserve in connection with the class action lawsuit that will adequately cover the cost of resolving the matter.

“We are pleased to put this matter behind us so we can continue focusing on growing our business through the ongoing sale of enzymes and the monetization of our C1 platform technology through potential licensing arrangements and other collaborations,” concluded Mark Emalfarb, President and Chief Executive Officer of Dyadic.

The litigation, Miller v. Dyadic International, Inc. et al, pending in the United States District Court for the Southern District of Florida, asserted class action claims under federal securities laws based on allegations of misstatements and omissions by Dyadic and certain of its current and former officers and directors arising out of alleged improprieties at Dyadic’s Asian subsidiaries. The final settlement of this lawsuit is conditioned upon the approval of a Stipulation of Settlement which has been submitted by the parties to the Court. The Stipulation of Settlement provides for payment to the alleged class of $4.8 million in cash to be funded by Dyadic and its insurance carriers. If approved by the Court, the settlement will lead to dismissal of the lawsuit with prejudice.

Dyadic has been involved in developing technology for producing biofuels from agricultural by products such as corn stover and wheat straw.

Last year, the company announced a licensing agreement with Abengoa Bioenergy to sell its patented C1 Technology Platform for the large-scale production of enzymes for use in manufacturing biofuels. They also announced a multi-million licensing agreement with Codexis, Inc in November.

Dyadic Founder and CEO Mark Emalfarb. Photo from TCPalm.com.

However, these recent successes did not come without hardship. As reported by the news media, in 2007 company founder, chief executive and largest shareholder, Mark Emalfarb, was forced out. Emalfarb once again took the company helm in 2008, although the outlook was much starker. During his absence, the stock price nearly dissapated and the shares were dropped from the American Stock Exhange and relegated to the Pink Sheets. But akin to the American success story, Emalfarb turned his company around with several big deals in 2009 and now they are poised as a leader going into 2010.

“With all the clouds lifted, people are seeing the sky very clearly — and it’s blue,” Emalfarb said in the Palm Beach Post. “Shareholders recognize the incredible, miraculous recovery we’ve made, and they’re rewarding us. We obviously are drinking our Kool-Aid.”

Today, the Biotechnology Industry Association is asking people to join their “I Am Biotech” movement.  If you join the online biotech community, you will be entered for a chance to win free roundtrip airfare and a complimentary registration to the 2010 BIO International Convention in Chicago.

The site offers insights on the direction of the industry from top CEO’s and thought leaders, networking opportunities, legislative updates, research updates and more. To learn more go to: www.IAmBiotech.org/join.

“In a few years sugar will be the new oil. Already today close to 200 biorefineries are operating in the U.S. and yet we have only seen the beginning. Industrial biotechnology today is a sector with a number of pioneers who are demonstrating that this is technically feasible,” says Steen Riisgaard, CEO of Novozymes. “However, to make the biobased economy into reality, they will require political backing. Novozymes is dedicated to helping ensure a radical shift in the way our societies work, and to reduce our dependency on oil.”

In 2008, the use of Novozymes’ technologies across industries resulted in the reduced CO2 emissions totaling more than 28 million tons – the equivalent of taking 4 million cars off the road.

“WWF sees industrial biotech as an industry that can play a very significant role in the development of a new, green economy if developed in the right way. The world can’t afford to ignore this opportunity,” says John Kornerup Bang, Head of Globalization Programme for WWF.

Click here to read the full press release. Click here to download the full report.

The interview was conducted as part of the Biotechnology Industry Organization’s (BIO) I am Biotech campaign. Emalfarb was asked several questions including the importance of biotechnology and biofuels, how biotechnology is helping to heal, fuel and feed the world, how do you demonstrate biotech is the way of the future, and more.

You can watch the first part of  Mark Emalfarb’s interview here and the second part by clicking here.

Chad Holliday with the GWCarver award and Mark Wright of Iowa State, the recipient of the Carver scholarship.

George Washington Carver is considered one of the founding fathers of modern industrial biotechnology and the award is given to companies who focus on continuing to develop products through sustainable agriculture. Carver’s work inspired leaders of the chemurgy movement, whose proponents looked for ways to replace petrochemicals with farm-derived products. Leaders of the chemurgy movement such as Charles Kettering and William Jay Hale proposed that anything made from a hydrocarbon could be made from a carbohydrate. Today, companies are using industrial biotechnology to manufacture plastics, chemicals, pharmaceuticals, and even food ingredients from renewable agricultural resources.

Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, said of Holliday’s accomplishments, “During Holliday’s tenure as CEO, DuPont invested in biology-based businesses and infused them with its chemistry know-how. For instance, DuPont partnered with sugar processor Tate & Lyle to manufacture 1,3 propanediol, a polyester ingredient made by fermenting sugar. That venture led the company to think about applying its fermentation expertise to making renewable fuels and chemicals in a biorefinery. Under the aegis of the Department of Energy, the firm has worked with several research partners to further the concept and make it commercially viable.”

“Market-driven science discovery and new product innovation are at the very core of DuPont’s business, and industrial biotechnology is a key component of that, ” said Holliday. “Innovation is essential to business growth that provides safer and more secure lives for people everywhere while addressing global energy and environmental challenges. On behalf of all DuPont employees around the world, I am deeply honored to receive an award that recognizes and promotes work toward this goal, especially as it is given by a group of peers who share this vision.”

Accompanying the award is a George Washington Carver scholarship given in the name of Charles O. Holliday, Jr., to Iowa State University graduate student Mark Wright, currently pursuing a Ph.D. in Mechanical Engineering and Biorenewable Resources and Technology. The award is sponsored by DSM, the Iowa Biotechnology Association and the Iowa Department of Economic Development.

The meeting is organized by the Society for Industrial Microbiology, hosted by the National Renewable Energy Laboratory and Oak Ridge National Laboratory, and sponsored by the Department of Energy’s Biomass Program. More information is available here.

Paul says the BP Energy Biosciences Institute was created as a place to apply modern biology to energy problems. He told us that from their perspective, the turbulant times we’re in right now are temporary and that the fundamental trends for the future are unchanged. Those being the supply of oil and gas and the growth and demand for energy products. He says that their CEO likes to say that, “the future has been delayed, it hasn’t been canceled.”

I think he made a good point in my interview with him that we shouldn’t panic. He says there are numerous technology efforts going on in the alternative fuels industry and that it would be a mistake to see that work evaporate because we live in a world of crisis. He urges a steady course toward the future. He also talks about the benefits of biotechnology in developing more efficient alternative fuel production but points out that the industry is still just in its infancy.

You can listen to my interview with Paul here: ff-global-09-willems.mp3

You can download the interview with this link (mp3).

You can find photos from the conference here:
Transition To A Bio Economy Conference: Global & Trade Issues Photo Album

His talk was on the distributional effects of biofeuls and he had two conclusions. The first one is that biofuels make some people better off and some people worse off. Drivers are better off since they’re getting their fuel for about 15 cents less than if it didn’t have biofuels in it but consumers of food are worse off since the price of food is higher. He says that’s worse in developing countries where they’re seeing food prices 20 to 40 percent higher. This situation he says is causing political instability which will become an obstacle to the development of biofuels.

His second conclusion is that we have to increase productivity. He says that if we don’t we’re in real trouble. In order to increase agricultural productivity he says we must use biotechnology in all crops.

You can listen to my interview with David here: ff-bio-08-zilberman.mp3

You can also download the interview using this link (mp3).

I’m also uploading pictures to a photo album which you can feel free to use if you’d like: Transition To A Bio Economy Photo Album

Biotechnology leaders from around the globe will be descending upon San Diego, one of the leading biotech hubs in the world, to discuss the most pressing issues and share their unique perspectives. In addition, there will be a total of 36 regional and country pavilions within the BIO Exhibition with several new pavilions, including Argentina, Brazil, Chile, Dubai, and South Africa.

This year’s keynote speakers include Gen. Colin Powell, J. Craig Venter, Ph.D., and Gov. Arnold Schwarzenegger.

Registration for attendees is offered at an early-bird discounted rate of nearly 40 percent off the regular rate until May 8, 2008 at www.bio2008.org/registration.The state of sustainable agriculture in developing countries will be one of the main issues addressed at the BIO International Convention this summer. The Biotechnology Industry Organization is hosting the convention in San Diego from Tuesday, June 17 through Friday, June 20.

Biotechnology leaders from around the globe will be descending upon San Diego, one of the leading biotech hubs in the world, to discuss the most pressing issues and share their unique perspectives. In addition, there will be a total of 36 regional and country pavilions within the BIO Exhibition with several new pavilions, including Argentina, Brazil, Chile, Dubai, and South Africa.

This year’s keynote speakers include Gen. Colin Powell, J. Craig Venter, Ph.D., and Gov. Arnold Schwarzenegger.

Registration for attendees is offered at an early-bird discounted rate of nearly 40 percent off the regular rate until May 8, 2008 at www.bio2008.org/registration.

Georgia Power and Yellow Pine Energy Company, LLC, a biomass-fired facility to be located near Fort Gaines, Ga., recently signed a 20-year contract for electricity that will be generated from environmentally-friendly wood waste. The material will come from timber harvesting residuals and collection of non-commercial tree species, tree-thinnings, lumber scraps and wood waste reclaimed from landfills.

The Yellow Pine facility is scheduled to go into operation in 2010 and will produce 110 megawatts of renewable energy. Under the contract, Georgia Power will purchase almost half of the plant’s capacity, or about 50 megawatts. One megawatt is enough energy to supply a Wal-Mart shopping center or 250 Georgia residences.

Georgia Power provides energy for 2.3 million consumers throughout the state.

According to a news release, the strategy was unveiled at a press conference during the 4th Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando, Fla. The press conference was followed by a panel discussion featuring Per Falholt, Novozymes chief scientific officer; Maria Rapoza, vice president for Science and Technology, North Carolina Biotechnology Center; and Dan Schwartzkopf, National Hot Rod Association dragster and Ethanol Promotion and Information Council representative.

The company’s strategy includes: continued funding of research and development, establishment of geographically-distributed flexible configuration testing and development centers, scientific advancement to increase cost efficiency by improving underlying agricultural practices and pre-treatment methods, scientific advancement in biotechnology, and continued bi-partisan support of a national infrastructure to support practical implementation such as incentives and tax credits.

According to the study, U.S. farmers gained an additional 8.3 billion pounds of yield last year due to biotech crops, including an extra 7.6 billion pounds of corn production, a 29 percent increase over 2004.

Since the commercialization of plant biotechnology in the late 1990s, corn production has benefited by an extra 39 billion pounds of yield, equivalent to 1.9 billion gallons of ethanol production. These continued yield increases will be a key factor in meeting future demand as corn prices hit 10-year highs and corn used for ethanol production is predicted to jump 34 percent in 2007.

Further, the report indicates biotech crops helped farmers increase their income by $2 billion last year, while reducing the amount of pesticides used 69.7 million pounds on the 123 million acres planted to the biotech-enhanced crops. In addition to herbicide-resistant and insect-resistant corn, the report evaluated the impact of herbicide-resistant soybean, herbicide-resistant and insect-resistant cotton, herbicide-resistant canola and virus-resistant squash and papaya.

Read the executive summary of the study here.

Link to press release.

DuPont has a significant effort to deliver new technologies to the growing biofuels market, which includes improving biofuel production through improved seed and crop protection products; developing new technologies to allow conversion of cellulose to biofuels; and developing next generation biofuels, including biobutanol. In addition to developing corn hybrids for ethanol, DuPont subsidiary Pioneer Hi-Bred International, Inc., is characterizing Pioneer® brand soybean varieties for oil content to determine impact on biodiesel production.

I interviewed Troy Hobbs, Business Manager, Bunge/Dupont Biotech Alliance. He describes the changes in more detail and what this means for producers. Troy is pictured on the left of the Treus sign. On the right is Jason Klootwyk, Bunge, Asst. Commercial Manager, Grain Division.

You can listen to my interview with Troy here: Troy Hobbs Interview (3 min MP3) Note: I wasn’t using my regular recorder but the audio is acceptable.

Full Release